Amplitude Ventures

Amplitude Ventures, established in 2018, is a Montreal-based venture capital firm specializing in early-stage investments. It focuses on biotechnology and healthcare sectors, primarily supporting emerging Canadian companies. The firm prefers minority stake investments and has successfully deployed a growth model to scale companies with world-class management teams. Since its inception, Amplitude has raised over $700 million and launched a $200-million fund in 2019, applying a proven, evidence-based approach to investing in leading Canadian precision medicine companies.

Anish Kaushal

Associate

Juliana Muñoz

Associate

Matthew Rosenberger

Vice President Finance

Allyson Tighe

Co-Founder and Associate

Past deals in Montreal

InVivo AI

Seed Round in 2021
InVivo AI, founded in 2017 and based in Montreal, Canada, specializes in utilizing artificial intelligence to enhance pharmaceutical research and development, particularly in the area of preclinical toxicology. The company aims to streamline the drug discovery process by implementing advanced AI methods for molecular representation and de novo design, which allows for the creation of novel chemical compounds that can address complex biological challenges. Through its innovative platform, InVivo AI is positioned to significantly improve the efficiency and effectiveness of drug design, paving the way for breakthroughs in pharmaceutical science.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.